Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders

  1. Lookup NU author(s)
  2. Dr Bridget Wilkins
  3. Dr Nicholas Simpson
Author(s)Haniffa MA, Wilkins BS, Blasdale C, Simpson NB
Publication type Article
JournalJournal of the American Academy of Dermatology
Year2006
Volume55
Issue2, Supplement
PagesS28-S31
ISSN (print)0190-9622
ISSN (electronic)1097-6787
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Cutaneous extramedullary hemopoiesis (EMH) is a rare complication of chronic myeloproliferative and myelodysplastic disorders. Chronic idiopathic myelofibrosis (CIMF) is the most common underlying condition. To date, fewer than 30 cases have been reported in the literature and there has been significant confusion with regard to the proposed pathogenesis. In this article, we describe two additional cases of cutaneous EMH associated with chronic myeloid diseases and review the literature with the aim of clarifying the underlying pathogenesis of this unusual clinical condition. The diagnosis of cutaneous EMH in both patients with chronic myeloid diseases was made histopathologically, with immunohistochemistry confirming the presence of differentiating hemopoietic cells associated with dermal components. Cutaneous EMH in chronic myeloid diseases occurs as a result of migration of abnormal neoplastic hemopoietic precursor cells into the skin (in effect, metastasis) and subsequent differentiation along divergent myeloid cell lineages. The diagnosis should be considered in any patient with chronic myeloproliferative or myelodysplastic disease who develops a skin rash.
PublisherElsevier
URLhttp://dx.doi.org/10.1016/j.jaad.2005.11.1038
DOI10.1016/j.jaad.2005.11.1038
NotesCase Reports Journal Article Review United States
Actions    Link to this publication